Portal de Molina de Segura
www.portaldemolina.com
Obeso Inchausti] | will be held on Wednesday 19 May |
The event was held at 20.00 pm in the auditorium of the College of Education Child Paseo Rosales
Medical Research Foundation of Molina de Segura (FEM) presented at a press conference today, Wednesday May 12, the next conference of scientific (number 54), to be held in Molina de Segura (College auditorium Child Education Paseo Rosales) elmiércoles May 19, 2010, at 20.00, with free entry, under the title of Parkinson's: New Challenges, by Dr. José Ángel Obeso Inchausti, Professor of Neurology and Chief of Service Clínica Universitaria de Navarra.
The conference is organized by the WEF, the city of Molina de Segura and the Hospital de Molina, sponsored by the Caixa.
The presentation was made by Maria Trinidad Herrero Ezquerro, Professor, Faculty of Medicine of the University of Murcia, and Josefina García Lozano, Secretary of the EMF.
Dr. José Obeso is a member of the board of the Department of Neurology, University Clinic of Navarra, where he heads the Movement Disorders Unit.
He is also Associate Professor in the Faculty of Medicine of the University of Navarra, and member of the Board of Neuroscience Center for Applied Medical Research (CIMA) in Pamplona.
Now combines his clinical and teaching activities with the direction of the research group of the Movement Disorders at the CIMA, where there are several lines of research related to fundamental aspects of Parkinson's disease, such as neural processes involved in the onset of dyskinesias or mechanisms that compensate for dopamine loss in the initial stages of the disease.
He graduated in Medicine from the University of Navarra in 1976, where he earned his doctorate in 1979, ending a specialty in Neurology at the University of the Basque Country.
Later, he moved to the laboratory of Prof. Marsden, King's College London (1980/1981), where he developed an extensive experimental work as electrophysiologist, working on the study and treatment of myoclonus.
He has worked in the Chiron Clinic in San Sebastian and Clinical Vintersol de Tenerife (1996/1999).
Since then he has developed an extensive clinical work, teaching and research at the University of Navarra and University Clinic in Pamplona, where he has directed numerous dissertations, graduate studies and specialties, and has developed lines of research such as the beneficial effects continuous dopaminergic stimulation, neurodegenerative progress of Parkinson's disease, the pathophysiology of the basal ganglia, and the surgical treatment of Parkinson's disease.
The results of these studies have been published in more than 170 articles in international journals, which have contributed to knowledge and understanding of the basal ganglia and their diseases by the international scientific community.
Hirsch has an index of 49.
Belongs to the editorial board of numerous journals of Neurology, among which Annals of Neurology, Movement Disorders and Neurology.
His professional work has been rewarded with various prizes and distinctions, among which are the Germania Rossetto International Award, awarded by the University of Pavia (Italy) in 1988, the conference BRAIN LECTURE's 1997: Advances in the Treatment of Parkinson's disease: The renaissance of surgery, held in Manchester (GB), and the prize awarded by the Swiss Parkinson's Society to the best researcher of the year in 2002.
He has also acted as scientific advisor to the Michael J.
Fox Foundation (USA), Anne Obretch Parkinson Foundation (Switzerland) and Dystonia Foundation (USA).
Parkinson disease (PD) is a neurodegenerative disease of the central nervous system whose main feature is the progressive death of neurons in a part of the brain called the substantia nigra.
The most important impact of this neuronal loss is a marked decrease in cerebral availability of dopamine, the main substance synthesized by these neurons, causing a malfunction in the regulation of key brain structures involved in movement control.
PD affects one million people in the European Union and over 100,000 in Spain, is characterized by a progressive motor disorder whose main symptoms are generalized clumsiness in performing slow movements, lack of spontaneous motility, resting tremor and stiffness.
According to Dr. Obeso, "the most urgent challenge today is early diagnosis to halt its progression."
Source: Ayuntamiento de Molina de Segura
Privacy policy
- Legal notice
- Cookies